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ABSTRACT
Leptin acts as satiety factor and increases energy expenditure.
Studies conducted on animals and in vitro on adipocytes culture have
shown that infusion of catecholamines leads to a significant reduction
of ob gene expression; it appears of interest to evaluate the in vivo
effects of adrenergic activation on the expression of the ob gene in
humans.
We studied ob gene expression in adipose tissue samples from 13
obese subjects before and after epinephrine (25 ng/minzkg ideal body
weight for 3 h) and 6 obese patients during saline infusion. Hormonal
infusion led to a significant increase in epinephrine plasma levels
(from 27 6 4 to 339 6 75 pg/mL; P , 0.001), plasma free fatty acids
(from 0.73 6 0.05 to 0.98 6 0.07; P , 0.05), heart rate (13.5 6 3.1
beats/min; F 5 2.9; P , 0.03), and systolic blood pressure (F 5 2.7; P ,
0.05), whereas diastolic blood pressure did not show significant vari-
ation. Plasma leptin levels decreased by the end of the infusion (from
63 6 13 to 49 6 11 ng/mL; P , 0.05), and ob messenger ribonucleic
acid levels were significantly reduced (decrease amounting to 47 6 5%
of basal values). Our study shows that adrenergic activation contrib-
utes to regulate ob messenger ribonucleic acid levels in humans. The
interaction between epinephrine and leptin may operate during met-
abolic and psychological stress to regulate energy expenditure and
food intake. (J Clin Endocrinol Metab 84: 3309–3312, 1999)
OBESITY is defined as increased mass of adipose tissueresulting from a systemic imbalance between caloric
intake and energy expenditure. This condition increases the
risk for a variety of cardiovascular and metabolic disorders,
including noninsulin-dependent diabetes mellitus. The mo-
lecular factors regulating food intake and body weight are
poorly understood. Recently, a major advance in our under-
standing has been achieved by Zhang and colleagues, who,
using positional cloning, have isolated the obese (ob) gene,
which causes severe hereditary obesity and noninsulin-
dependent diabetes mellitus in mice when mutated (1). This
gene is expressed in both sc and visceral white adipose tissue
and codes for a 18,000 molecular mass protein with a signal
sequence. It is suggested that the protein, termed leptin, is
secreted from white adipocytes as a 16,000 molecular mass
product that signals the size of the white adipose tissue
depots (1, 2). Circulating leptin levels change in parallel with
changes in adipose tissue messenger ribonucleic acid
(mRNA) levels (1, 2). Human obesity does not appear to be
caused by mutations in the ob gene, but it might be due to
resistance to leptin (3, 4). However, about 10% of obese
patients have relatively low leptin levels; therefore, it has
been suggested that obesity could be secondary to an ab-
normal regulation of the leptin gene that leads to a relative
decrease in the synthesis of leptin mRNA (5). The expression
of the ob gene is subject to nutritional regulation; the level of
ob mRNA falls during fasting and rises with refeeding (6, 7).
Hormonal factors, such as glucocorticoids and insulin, are
involved in regulation of the ob gene in rats, but controversy
exists on their role in humans (8–10). Trayhurn and col-
leagues (11) have shown that acute exposure of mice to cold
led to suppression of the ob gene, and the same effect could
be mimicked by the administration of norepinephrine and
b3-adrenoceptor agonist; the effect of cold on the ob gene was
therefore mediated primarily by the sympathetic nervous
system in animals. On the other hand, it is well known that
the sympathoadrenal system plays an important role in en-
ergy expenditure (EE) by affecting its different components,
such as the basal metabolic rate and food-induced and
exercise-induced EE (12). All of these data taken together
suggest that the sympathoadrenal system plays a role in the
maintenance of body weight affecting both EE and food
intake and in regulating the expression of the ob gene, in the
pathogenesis of obesity. The relationship between the leptin
axis and the adrenergic system in human obesity has not
been investigated. The aim of this study was to evaluate the
effect of sympathoadrenal system activation, obtained by
epinephrine administration, on leptin gene expression in
human obese subjects.
Subjects and Methods
Nineteen obese patients were recruited for the study. The clinical
characteristics of the patients are shown in Table 1. We studied 13 obese
subjects before and during epinephrine infusion (9 women and 4 men),
whereas 6 obese patients (4 women and 2 men) were recruited as con-
trols and studied during saline infusion without epinephrine. The sub-
jects had been weight stable from at least 6 months before the time of
presentation and were free from clinical and laboratory signs of car-
diovascular or metabolic disease other than obesity; none of them was
taking any medication. The protocol was approved by the local ethics
committee, and all the subjects gave informed consent to enter the study.
Protocol
Epinephrine infusion. On arrival, a 19-gauge iv catheter, for blood sam-
pling, was inserted into a vein of the forearm and kept patent with a slow
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running infusion of saline. A second catheter was placed in a contro-
lateral antecubital vein for the infusion of epinephrine at the dose of 25
ng/minzkg ideal body weight (IBW) (13) for 3 h. The epinephrine in-
fusates (Laboratorio Chimico Biologico SRL, Venice, Italy) were pre-
pared as 1 mg/mL solutions in saline, with 1 mg/mL ascorbic acid added
as preservative. Heart rate and systolic and diastolic blood pressure
were monitored by using an automated cuff device during the test
(Lifestat, Physiocontrol, Richmond, VA). Blood samples were taken at
5 and 0 min before the infusion and at 60, 120, 150, and 180 min during
the epinephrine and saline infusions to evaluate concentrations of leptin
and epinephrine and free fatty acids (FFA). Leptin was determined by
RIA (Human Leptin Ria Kit, Linco Research, Inc., St. Charles, MO);
catecholamines were determined by reverse phase high performance
liquid chromatography with electrochemical detection (14). Plasma FFA
were measured by enzymatic colorimetric assay (Roche Molecular Bio-
chemicals, Lewes, UK). Samples of sc abdominal adipose tissue were
obtained, before and after the epinephrine infusion, by means of a new
liposuction technique (15), using a 20-cm long, 4-mm wide liposuction
cannula connected to a 10-mL syringe to obtain a 5- to 7-mL sample. The
specimens were taken from a triangle-shaped area, with the tip at the
edge of the umbilicus and the base 5–7 cm lateral and below. The
procedure, carried out under local anesthesia, was well tolerated.
RNA extraction and preparation of human ob
complementary DNA (cDNA)
Total cellular RNA was extracted using a modification of the gua-
nidium-cesium chloride centrifugation technique. Briefly, the adipose
tissue biopsy was lysed in 4 mol/L guanidium thiocyanate, and RNA
was pelleted by ultracentrifugation through a cesium chloride cushion
(5.7 mol/L CsCl and 0.1 mol/L ethylenediamine tetraacetate, pH 7.5).
Total RNA was recovered, extracted with phenol-chloroform, precipi-
tated with ethanol, and resuspended in sterile, double distilled water
supplemented with ribonuclease inhibitor (RNAsin; 0.2 U/L; Roche
Molecular Biochemicals, Mannheim, Germany). Ethidium bromide
staining of a 1.1% agarose/formaldehyde minigel was used to check the
integrity of isolated RNA and to confirm the presence of equivalent
amounts of RNA in each lane. RT-PCR was carried out using 3 mg total
RNA extracted from an adipose tissue biopsy, reverse transcribed using
200 U SuperScript II Reverse Transcriptase (Life Technologies, Inc.,
Gaithersburg, MD) and 0.5 mg oligo(deoxythymidine)15 primer (Roche
Molecular Biochemicals).
One microliter of cDNA was then amplified by adding 2.5 U Expand
High Fidelity Polymerase (Boehringer Mannheim, Mannheim, Ger-
many), 0.5 mg direct primer, and 0.5 mg reverse primer. Oligonucleotide
primers were synthesized on a solid phase synthesizer (model 394,
Applied Biosystems, Inc., Foster City, CA). The primers enclose the
coding sequence corresponding to nucleotides 22–55 and 561- 594 of the





Human ob cDNA was labeled using the random prime labeling pro-
cedure described by Feinberg and Volgelstein (16). The specific activities
obtained ranged from 1–3 3 109 cpm/mg DNA.
Northern blot analysis
The total cellular RNA was extracted as described above. Ten mi-
crograms of RNA for each lane were loaded onto a 1.1% agarose/
formaldehyde gel in 1 3 4-morpholine propanesulfonic acid buffer. The
RNA was transferred to a positively charged nylon membrane (Roche
Molecular Biochemicals) using the electroblotting procedure. After UV
fixation of the transferred RNA, the membrane was prehybridized in 6 3
SSC (standard saline citrate)-5 3 Denhardt’s solution-0.5% SDS and then
hybridized in 6 3 SSC-5 3 Denhardt’s solution-10% dextrane sulphate-
0.5% SDS with 32P-labeled probe and then washed with 0.1 3 SSC-0.5%
SDS at 65 C for several hours. Autoradiography was performed using
intensifying screen at 280 C. The films were analyzed using a soft laser
densitometer scanner. A further densitometric scanning of ethidium
bromide staining of the gel was used to normalize the ob mRNA abun-
dance. Data were analyzed using repeated measures ANOVA (17) or
paired t test when appropriate.
Results
As a result of the epinephrine infusion, the mean plasma
epinephrine levels increased from 27 6 4 to 339 6 75 pg/mL
at the end of the infusion (P , 0.001). A small, but significant,
increase in systolic blood pressure (F 5 2.7; P , 0.05; Fig. 1)
was observed, whereas diastolic blood pressure did not
change during epinephrine infusion (F 5 1.4; P 5 NS; Fig. 1);
by the end of the infusion heart rate had risen by 13.5 6 3.1
beats/min (F 5 2.9; P , 0.03; Fig. 1). As a result of epineph-
rine infusion, plasma FFA increased from a basal value of
0.73 6 0.05 to 0.98 6 0.07 mmol/L at 180 min (P , 0.05; Fig.
2). Leptin levels during the infusion decreased from 63 6 13
to 61 6 12 ng/mL at 60 min (P 5 NS), 52 6 9 at 120 min, 46 6
TABLE 1. Anthropometric features of the subjects included in the
study
No. of patients 19
Age (yr) 42.1 6 2.2
Ht (cm) 164.2 6 3.2
Wt (kg) 133.8 6 7.5
BMI 49.6 6 2.4
W/H 1.00 6 0.05
FM (kg) 63.9 6 5.8
FFM (kg) 69.5 6 4.4
Data are the mean 6 SEM.
FIG. 1. Systolic and diastolic blood pressure and heart rate during
epinephrine infusion (25 ng/minzkg IBW; filled circles) and during
saline infusion (open circles). Results are the mean 6 SEM. *, P , 0.05
vs. basal values.
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11 at 150 min, and 49 6 11 ng/mL at 180 min (P , 0.05 for
all vs. basal value); in parallel, the expression of leptin mRNA
in adipose tissue fell markedly in all patients studied (Fig. 3);
the decrease was 47 6 5% of the basal values (P , 0.001; Fig.
4). No significant correlation was found between plasma FFA
and plasma leptin during epinephrine infusion (r 5 20.19;
P 5 NS), whereas the percent decrease in leptin ob mRNA
was inversely correlated with basal plasma leptin (r 5 20.64;
P , 0.05). In the control group no changes were observed in
pulse rate or blood pressure (Fig. 1). Plasma epinephrine did
not change (from 30 6 3 to 28 6 4 pg/mL; P 5 NS), nor did
plasma FFA (from 0.65 6 0.07 to 0.67 6 0.08 mmol/L, P 5
NS; Fig. 2), plasma leptin (from 56 6 15 to 52 6 16 ng/mL;
P 5 NS), and leptin mRNA (mean change from basal value,
5 6 4%; P 5 NS; Fig. 4).
Discussion
In this study we provide evidence for the first time that
increased plasma epinephrine levels are able to acutely reg-
ulate ob gene expression in white adipose tissue of obese
subjects. The decrease in ob gene expression was detected in
all of the patients studied; these data together with previous
findings support the concept that ob gene expression is under
hormonal control (8–10). Adipose tissue is highly innervated
in humans, and both sympathetic and parasympathetic ac-
tivities regulate its function (18, 19). Several studies in ani-
mals have demonstrated a strict relationship between ad-
renergic activation and leptin (11, 20, 21). In addition, a study
conducted in vitro on adipocyte coculture has shown that
administration of norepinephrine and isoproterenol reduced
the level of leptin mRNA, and this effect was reversed par-
tially by the administration of propanolol (22). The admin-
istration of a b3-adrenergic receptor agonist in mice pro-
duced acute suppression of ob gene expression in white
adipose tissue (20). The absence of this effect in b3-receptor
knockout mice supports the view that the suppression of the
ob gene in adipocytes is mediated by a b3-receptor through
a Gs protein-coupled pathway (21).
Observations in humans are lacking. It has been shown
that circulating leptin is rapidly (within 2 h) and reversibly
suppressed by isoprenaline infusion in humans (23). Our
data agree with this finding, as we observed a similar de-
crease in plasma leptin levels (;20% of basal values) in obese
patients during epinephrine infusion. Assessment of arterio-
venous differences of leptin release from adipose tissue
seems to be a more sensitive technique for detecting changes
in secretion than measurement of the systemic concentration,
and it is possible that our data indeed underestimate the
effect of adrenergic activation on leptin secretion in vivo (24).
Knowledge of the mechanisms that modulate leptin gene
expression is therefore important to understand the interin-
dividual variability in plasma leptin levels.
Indeed, plasma leptin levels in obese subjects may be high
or normal; however, a small fraction of patients shows rel-
atively low leptin levels. Recently, it has been demonstrated
that alterations in the regulatory elements of the ob gene may
lead to an abnormal response to cold in mice, and the re-
searchers asserted that in some cases abnormal regulation of
the leptin gene may be an etiological factor in the pathogen-
esis of obesity in humans (5).
The sympathetic nervous system and the adrenal medulla
play an important role in the control of EE (12). Indeed, in
humans, the plasma epinephrine threshold for metabolic
effects, including lypolysis and stimulation of EE, lies within
the physiological range (25). The epinephrine infusion rate
used in our study has proved to be effective in stimulating
lypolysis and metabolic rate in both lean and obese subjects
(13), and the epinephrine concentration reached at the end of
the study is similar to that seen during hypoglycemia and
strenuous exercise (25). Therefore, it would be interesting to
study the leptin variation in vivo during different metabolic
FIG. 2. Plasma FFA levels during epinephrine infusion (25 ng/minzkg
IBW; filled circles) and during saline infusion (open circles). Results
are the mean 6 SEM. *, P , 0.05 vs. basal values.
FIG. 3. Northern blot analysis of human ob mRNA 1) before and 2) after epinephrine infusion in 13 obese subjects. Total RNA (10 mg/lane) was
used.
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challenges in humans and its relationship to the adrenergic
system in vivo. Leptin may acts as a satiety factor, but there
is evidence that it also affects energy expenditure. Studies
conducted in vivo on mice have shown that daily ip injection
of these mice with recombinant OB protein lowered their
body weight, percent body fat, food intake, and serum con-
centration of glucose and insulin (26); in addition, metabolic
rate, body temperature, and activity levels were increased,
suggesting that the OB protein regulates body weight and fat
deposition as well as EE (2, 4). Fasting is another situation in
which a relationship between the adrenergic system and
leptin could be hypothesized. Actually, the fall in plasma
leptin levels during fasting is associated with an increase in
epinephrine and a decrease in norepinephrine plasma levels,
but does not seem to be linked to changes in insulin or
ketones (6, 27). A putative influence of FFA on leptin levels
has been suggested; recent papers indicate that plasma leptin
concentrations are not correlated with changes occurring in
plasma FFA without concomitant adrenergic activation (28,
29). Finally, epinephrine is also part of the physiological
response to stress, and recently, leptin has been claimed to
be a stress-related hormone, able to modulate the hypotha-
lamic-pituitary-adrenal axis (30). The interaction between
epinephrine and leptin may, therefore, operate during met-
abolic and psychological stress to regulate EE and food
intake.
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